Founded in 2008 by industry executive Anup Dam, privately owned STI Pharma develops, licenses, acquires and commercializes generic medicines. The company manages product development and regulatory support in-house, while its commercial products are made at FDA-registered partner facilities and distributed across the United States and its territories. STI is particularly active in specialty and injectable generics, including recent launches such as thiotepa and isoproterenol hydrochloride.
FDA-Registered Manufacturing Facilities
registration
cGMP Standards
compliance_program
XGen Pharmaceuticals DJB, IncFounded in 1972 by Dan Badia and his wife, Shirley Harmening, XGen Pharmaceuticals DJB develops and supplies affordable generic pharmaceuticals, with a focus on injectables for hospitals, clinics and institutional customers. The privately held, family-owned and woman-owned company grew from a three-product operation in Northport, New York into a Horseheads-based business whose portfolio preserves essential past-patent treatments, including products such as eribulin mesylate injection. XGen DJB holds NABP accreditation and reports more than 50 years of experience in generic pharmaceuticals.BIG FLATS, NY
Slate Run PharmaceuticalsFounded in Columbus, Ohio, in 2014, Slate Run Pharmaceuticals is a pharmaceutical company led by industry veterans with more than 200 years of combined experience in generic medicines. The company supplies FDA-approved pharmaceuticals to healthcare customers, with a particular focus on dependable access to generic injectables.COLUMBUS, OH
ScieGen PharmaceuticalsFounded in 2009, ScieGen Pharmaceuticals develops and manufactures finished-dose generic medicines, with its products made in the United States at cGMP facilities in Hauppauge, New York. Its Long Island operation spans more than 250,000 square feet and is designed for annual production of over 10 billion tablet and capsule units, supported by formulation and analytical research in Hyderabad, India. The company has filed more than 75 ANDAs and distributes generic drugs across a broad range of therapeutic categories.HAUPPAUGE, NY
BionpharmaFounded in 2014, Bionpharma develops, manufactures, markets, and distributes generic prescription and over-the-counter medicines for U.S. and international markets. The company operates a full-scale pharmaceutical platform with research and development capabilities, a manufacturing site in Chennai, India, and more than 50 marketed drugs. Bionpharma is also one of the largest suppliers of softgel capsules in the United States and has sold its A+ Health OTC line through Amazon since 2019.FLORIDA, NY